TY  - GEN
AU  - McGuire,William P
AU  - Penson,Richard T
AU  - Gore,Martin
AU  - Herraez,Antonio Casado
AU  - Peterson,Patrick
AU  - Shahir,Ashwin
AU  - Ilaria,Robert
TI  - Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
SN  - 1471-2407
PY  - 2019///0415
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - pharmacology
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carcinoma, Ovarian Epithelial
KW  - drug therapy
KW  - Cisplatin
KW  - Constipation
KW  - chemically induced
KW  - Doxorubicin
KW  - analogs & derivatives
KW  - Drug Resistance, Neoplasm
KW  - Fatigue
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Mucositis
KW  - Nausea
KW  - Neoplasm Recurrence, Local
KW  - Ovarian Neoplasms
KW  - Polyethylene Glycols
KW  - Progression-Free Survival
KW  - Receptor, Platelet-Derived Growth Factor alpha
KW  - antagonists & inhibitors
KW  - Time Factors
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1186/s12885-018-5198-4
ER  -